Cookie notice

This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.
Find out more about how we use cookies and how to manage them by reading our cookie notice.

  • About our use of cookies
  • Go to navigation
  • Go to content
AstraZeneca Internationall

AstraZeneca Global

  • Investors
  • Media
  • Careers
  • Healthcare professionals
  • Patients

Other AZ websites

Quick Links

  • Calendar
  • Photo library
  • Media Contacts
  • Financial information
  • AstraZeneca in the US
  • AstraZeneca Annual Report 2012
  • Follow us on Twitter
  • AstraZeneca Careers Site
  • MedImmune

AstraZeneca Worldwide

Americas

  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Mexico
  • United States
  • Uruguay
  • Venezuela

Asia-Pacific

  • Australia
  • China
  • Hong Kong
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • The Philippines

Europe

  • Belgium
  • Bulgaria
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Middle East & North Africa

  • Turkey
  • Home
  • About Us
    • Our strategy
    • What we do
    • Key facts
    • Board & management
    • Social media
    • Features
    • Worldwide locations
    • History
    • Glossary of terms
  • Medicines
    • Cardiovascular
    • Gastrointestinal
    • Infection
    • Neuroscience
    • Oncology
    • Respiratory
    • Products A-Z
  • Research
    • Introduction
    • Capabilities
    • Our pipeline
    • Path to new medicines
    • Focus on disease
    • Collaborations
    • Events
    • Our global reach
    • Research news
    • R&D in the press
    • AstraZeneca Nobel Medicine Initiative
  • Partnering
    • What we offer partners
    • Our partnering process
    • Areas of interest
    • Regional opportunities
    • Contact us
    • Meet us at events
    • Case studies
    • Latest partnering news
  • Responsibility
    • Introduction
    • Sales & marketing practice
    • Access to healthcare
    • Research ethics
    • Human rights
    • Our people
    • Working with suppliers
    • Patient safety
    • The environment
    • Community investment
    • Governance & management
    • Code, policies & standards
    • Reporting performance
Investors
  • Corporate governance
  • Shareholder information
  • Investor tools
  • Financial information
  • Presentations & webcasts
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999
  • SEC filings
  • Directors' shareholdings
  • Annual reports
  • Investor contacts

You are here

  • Investors
  • Presentations & webcasts
  • 2000

2000 Presentations

200 full year results presentation

8 February 2001

Downloads

  • Presentation (PDF 83kb)

2000 AstraZeneca R&D update and site visit, AstraZeneca Mölndal, Sweden

12 December 2000

Downloads

  • Press release (PDF 26kb)
  • Discovery - Jan M Lundberg (PDF 3930kb)
  • Cardiovascular - Hamish Cameron (PDF 1688kb)
  • Gastrointestinal - part 1 - Hans Glise (PDF 144kb)
  • Gastrointestinal - Part 2 - Martin Nicklasson (PDF 272kb)
  • Therapy area update - Claes Wilhelmsson (PDF 1185kb)
Bookmark & Share

Legal Notices

  • Contact us
  • Legal notice and Terms of Use
  • Privacy notice
  • About our use of cookies
  • © AstraZeneca 2013

This website uses cookies. By continuing to use this website you consent to the use of cookies to enable functionality included in this website. You can understand more about our use of cookies on this page.

This website is intended for people seeking information on AstraZeneca's International business. We also have national business sites; links to these are under 'Other AZ websites' at the top of the page.